Moderna Faces Suspension Over Covid Jab Breaches

Moderna could face suspension from Britain’s pharmaceutical trade body following a string of breaches of the regulatory code.

The Covid vaccine maker is due to be audited by the Prescription Medicines Code of Practice Authority (PMCPA) over “unacceptable” practices that brought discredit upon the industry.

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of the British Pharmaceutical Industry (APBI).

It follows several code breaches, including representatives of the company offering children £1,500 and teddy bears to take part in Covid vaccine trials.

In a fresh ruling, which is expected to be published in the coming days, the company was also found to have misled regulators about when it first became aware of the financial incentives to children.